MX2014003939A - Sistema farmaceutico para la administracion oral de sustancias terapeuticas sensibles. - Google Patents

Sistema farmaceutico para la administracion oral de sustancias terapeuticas sensibles.

Info

Publication number
MX2014003939A
MX2014003939A MX2014003939A MX2014003939A MX2014003939A MX 2014003939 A MX2014003939 A MX 2014003939A MX 2014003939 A MX2014003939 A MX 2014003939A MX 2014003939 A MX2014003939 A MX 2014003939A MX 2014003939 A MX2014003939 A MX 2014003939A
Authority
MX
Mexico
Prior art keywords
therapeutic substances
oral administration
pharmaceutical system
administration
sensitive therapeutic
Prior art date
Application number
MX2014003939A
Other languages
English (en)
Other versions
MX359973B (es
Inventor
David Quintanar Guerrero
Laura Elizabeth Hernández Rizo
Original Assignee
Univ Nac Autónoma De México
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nac Autónoma De México filed Critical Univ Nac Autónoma De México
Priority to MX2014003939A priority Critical patent/MX359973B/es
Priority to US15/129,714 priority patent/US20170172928A1/en
Priority to PCT/MX2015/000052 priority patent/WO2015152704A1/es
Publication of MX2014003939A publication Critical patent/MX2014003939A/es
Publication of MX359973B publication Critical patent/MX359973B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/02—Processes for applying liquids or other fluent materials performed by spraying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2258/00—Small objects (e.g. screws)
    • B05D2258/02—The objects being coated one after the other

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere específicamente a un sistema farmacéutico para la fabricación de formas farmacéuticas sólidas para la administración de sustancias terapéuticas mejorando su biodisponibilidad en particular el sistema es adecuado para administrar principios activos sensibles por su naturaleza protéica o por ser ácidos nucléicos, ya que se emplean excipientes poliméricos con buenas propiedades matriciales y de bioadhesión, que en conjunto con la impermeabilidad conferida por el recubrimiento aplicado, hacen del sistema elaborado una forma de administración de excelente desempeño.
MX2014003939A 2014-04-01 2014-04-01 Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles. MX359973B (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2014003939A MX359973B (es) 2014-04-01 2014-04-01 Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles.
US15/129,714 US20170172928A1 (en) 2014-04-01 2015-03-25 Pharmaceutical system for oral delivery of sensitive therapeutic substances
PCT/MX2015/000052 WO2015152704A1 (es) 2014-04-01 2015-03-25 Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014003939A MX359973B (es) 2014-04-01 2014-04-01 Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles.

Publications (2)

Publication Number Publication Date
MX2014003939A true MX2014003939A (es) 2015-09-30
MX359973B MX359973B (es) 2018-10-05

Family

ID=54240908

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003939A MX359973B (es) 2014-04-01 2014-04-01 Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles.

Country Status (3)

Country Link
US (1) US20170172928A1 (es)
MX (1) MX359973B (es)
WO (1) WO2015152704A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007913A2 (en) * 2001-07-20 2003-01-30 Samir Mitragotri Method for oral drug delivery

Also Published As

Publication number Publication date
WO2015152704A1 (es) 2015-10-08
MX359973B (es) 2018-10-05
US20170172928A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
MX2021001118A (es) Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.
BR112019024747A2 (pt) formulações de dose fixa
BR112012029912A2 (pt) vácinas de combinação de nanotransportadores sintéticos
CY1119957T1 (el) Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος
PH12018501072A1 (en) Modified release orally administered amino acid formulations
ECSP16084317A (es) Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
BR112017000898A2 (pt) oritavancina de alta pureza e método de produção da mesma
EP3858846A4 (en) NUCLEIC ACID NANO-CARRIER MEDICINE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION THEREOF, AND CORRESPONDING USE
BR112017009510A2 (pt) composições compreendendo ciclosporina
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
ECSP15022442A (es) Producto de comicronización que comprende acetato de ulipristal
BR112018071363A2 (pt) composições farmacêuticas orais de nicotinamida
MX364946B (es) Sistema adyuvante mejorado para la administración de vacunas orales.
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
WO2015001541A3 (en) Pharmaceutical film composition
MD20180049A2 (ro) Compoziţie farmaceutică
MY192073A (en) Rhinovaccination system of influenza vaccine
PH12018500011A1 (en) Composite preparation of mosapride and rabeprazole
WO2018119108A8 (en) Solid pharmaceutical formulations of asimadoline
MX359973B (es) Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles.
BR112018069440A2 (pt) forma de dosagem oral
WO2014013090A3 (en) Formulation comprising amorphous fingolimod
WO2016055111A8 (en) Amphiphilic copolymers their preparation and use for the delivery of drugs

Legal Events

Date Code Title Description
FG Grant or registration